JAK2 mutation and thrombosis in the myeloproliferative neoplasms.
Vannucchi, Alessandro M
JAK2 mutation and thrombosis in the myeloproliferative neoplasms. [electronic resource] - Current hematologic malignancy reports Jan 2010 - 22-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1558-822X
10.1007/s11899-009-0038-x doi
Amino Acid Substitution
Aspirin--therapeutic use
Cardiovascular Diseases--epidemiology
Clinical Trials as Topic
Fibrinolytic Agents--therapeutic use
Humans
Incidence
Interferon-alpha--therapeutic use
Janus Kinase 2--genetics
Multicenter Studies as Topic
Mutation, Missense
Myeloproliferative Disorders--blood
Phenotype
Point Mutation
Quinazolines--therapeutic use
Thrombophilia--enzymology
Thrombosis--epidemiology
JAK2 mutation and thrombosis in the myeloproliferative neoplasms. [electronic resource] - Current hematologic malignancy reports Jan 2010 - 22-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1558-822X
10.1007/s11899-009-0038-x doi
Amino Acid Substitution
Aspirin--therapeutic use
Cardiovascular Diseases--epidemiology
Clinical Trials as Topic
Fibrinolytic Agents--therapeutic use
Humans
Incidence
Interferon-alpha--therapeutic use
Janus Kinase 2--genetics
Multicenter Studies as Topic
Mutation, Missense
Myeloproliferative Disorders--blood
Phenotype
Point Mutation
Quinazolines--therapeutic use
Thrombophilia--enzymology
Thrombosis--epidemiology